FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to chronomedicine, endocrinology, dietology and therapy, and can be used to assess individual metabolic risk by circadian light hygiene. Following factors are taken into account in points: the latitude of the region of residence taking into account the seasonality of the assessment calculation, the obtained daytime and evening melanopic light exposure according to actigraphy data, the polymorphism of the melatonin receptor MTNR1B rs10830963 and the clock gene polymorphism CLOCK rs1801260. Further, the scores are summed up and the metabolic risk is assessed as a minimum with a total score of 5 and less, an average risk with a total score of 6 to 10, inclusive, and a high metabolic risk with a total score of 11 and more.
EFFECT: method provides an objective assessment of the individual metabolic risk by circadian light hygiene by taking into account the factors modifying the effect on metabolism.
2 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING INDIVIDUAL METABOLIC RISK BY CIRCADIAN LIGHT HYGIENE | 2024 |
|
RU2828989C1 |
METHOD FOR QUANTITATIVE ASSESSMENT OF CIRCADIAN EQUILIBRIUM ACCORDING TO ACTIGRAPHY DATA | 2024 |
|
RU2834158C1 |
METHOD FOR INTEGRATIVE ASSESSMENT OF SLEEP IN ACTIGRAPHY | 2024 |
|
RU2833895C1 |
METHOD FOR DETERMINING BLOOD TRIGLYCERIDES TAKING INTO ACCOUNT BIOLOGICAL CLOCK PHASE | 2024 |
|
RU2834162C1 |
METHOD FOR DIAGNOSING TRUE VALUE OF HIGH-DENSITY LIPOPROTEINS TAKING INTO ACCOUNT BLUE LIGHT PHASE | 2024 |
|
RU2834161C1 |
METHOD FOR DIAGNOSIS OF LIGHT DESYNCHRONOSIS | 2020 |
|
RU2748686C1 |
METHOD OF PREVENTION OF THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2023 |
|
RU2799582C1 |
METHOD FOR ASSESSING THE RISK OF TYPE 2 DIABETES MELLITUS BASED ON THE AVERAGE ADJUSTED SLEEP PHASE ACCORDING TO THE MUNICH TEST | 2022 |
|
RU2786822C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING OVERWEIGHT AND OBESITY BASED ON ANALYSIS OF CIRCADIAN RHYTHM GENE POLYMORPHISMS | 2024 |
|
RU2835187C1 |
METHOD FOR ESTIMATING THE RISK OF OCCURRENCE OF PSYCHOLOGICAL SLEEP AND MOOD DISORDERS BASED ON THE ADJUSTED AVERAGE SLEEP STAGE ACCORDING TO THE MUNICH QUESTIONNAIRE | 2021 |
|
RU2762914C1 |
Authors
Dates
2024-11-19—Published
2024-05-23—Filed